Benzopyrans as selective estrogen receptor β agonists (SERBAs). Part 2: Structure–activity relationship studies on the benzopyran scaffold
摘要:
Benzopyrans are selective estrogen receptor (ER) 0 agonists (SERBAs), which bind the ER subtypes a and in opposite orientations. Here we describe structure-activity relationship studies that led to the discovery of bezopyran 5b. X-ray crystal structures of 5b and a non-selective analog 5c in ER alpha help explain the observed selectivity of the benzopyran platform. (c) 2007 Elsevier Ltd. All rights reserved.
Benzopyrans as selective estrogen receptor β agonists (SERBAs). Part 2: Structure–activity relationship studies on the benzopyran scaffold
摘要:
Benzopyrans are selective estrogen receptor (ER) 0 agonists (SERBAs), which bind the ER subtypes a and in opposite orientations. Here we describe structure-activity relationship studies that led to the discovery of bezopyran 5b. X-ray crystal structures of 5b and a non-selective analog 5c in ER alpha help explain the observed selectivity of the benzopyran platform. (c) 2007 Elsevier Ltd. All rights reserved.
Substituted benzopyrans as selective estrogen receptor-beta agonists
申请人:ELI LILLY AND COMPANY
公开号:EP1790644A1
公开(公告)日:2007-05-30
The present invention relates to substituted benzopyran derivatives, stereoisomers, and pharmaceutical acceptable salts thereof and processes for the preparation of the same. The compounds of the present invention are useful as Estrogen Receptor β agonists. Such agonists are useful for the treating Estrogen Receptor β mediated diseases such as prostate cancer.